Cytotoxiv agents comprising new tomaymycin derivatives and their therapeutic use
申请人:SANOFI
公开号:EP2386559A1
公开(公告)日:2011-11-16
The present invention is related to new tomaymycin derivatives of formula (I), their process of preparation and their therapeutic uses.
本发明涉及式(I)的新型托美霉素衍生物、其制备工艺及其治疗用途。
US8163736B2
申请人:——
公开号:US8163736B2
公开(公告)日:2012-04-24
[EN] CYTOTOXIC AGENTS COMPRISING NEW TOMAYMYCIN DERIVATIVES AND THEIR THERAPEUTIC USE<br/>[FR] AGENTS CYTOTOXIQUES COMPRENANT DE NOUVEAUX DÉRIVÉS DE TOMAYMYCINE ET LEURS APPLICATIONS THÉRAPEUTIQUES
申请人:SANOFI AVENTIS
公开号:WO2007085930A1
公开(公告)日:2007-08-02
[EN] The present invention is related to new tomaymycin of formula (I) derivatives, their process of preparation and their therapeutic uses . [FR] La présente invention concerne de nouveaux dérivés de tomaymycine de formule (I), leur procédé de synthèse et leurs applications thérapeutiques.
A new and mild method for the reduction of secondary amides to carbinolamine ethers and imines: a conversion of oxotomaymycin to tomaymycin
作者:T. Kaneko、H. Wong、T.W. Doyle
DOI:10.1016/s0040-4039(00)88387-2
日期:1983.1
A new and mildmethod for reducing 2° amides to carbinolamine ethers and imines and its use in the synthesis of pyrrolo[1,4]benzodiazepine antibiotics is reported.